Metagenomic analysis reveals the novel role of vaginal Lactobacillus iners in Chinese healthy pregnant womenOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers examined vaginal microbiota in 95 Chinese women in their third trimester, comparing 34 healthy participants to 61 with diagnosed conditions such as gestational diabetes or adverse pregnancy outcomes.
How was it studied?
The team performed vaginal metagenomic sequencing to profile species, functional pathways, and genes, then used correlation and LEfSe analyses to link microbiota features to health status. They also isolated seven Lactobacillus iners strains and tested biofilm formation and growth inhibition of Gardnerella vaginalis in the lab.
What did they find?
Healthy women had higher levels of Lactobacillus iners, linked to tetrahydrofolate biosynthesis, plus more glycosyltransferase and ErmB resistance genes. Three bacterial-vaginosis-associated L. iners strains carried more biofilm-related YhgE/Pip genes and formed stronger biofilms than four healthy-associated strains, and four of seven strains inhibited Gardnerella vaginalis growth.
Why it matters
The findings suggest Lactobacillus iners is not uniformly harmful in pregnancy; strain-level genetic differences, not just species presence, may determine whether it supports or undermines vaginal ecosystem stability.